Review of Selected Aspects of Pharmacology
Authors: JOHN E. BENNETT
Journal: Annals of Internal Medicine (1964)

Clinical Staff Conference1 August 1964Review of Selected Aspects of PharmacologyJOHN E. BENNETT, M.D.JOHN E. BENNETT, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-61-2-335 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptBACKGROUNDIn the past few decades, countless microorganisms have been studied for their ability to produce useful antibiotics. It is a curious fact that the majority of clinically effective antibiotics, including amphotericin B (1), have been produced by actinomycetes (2). Among the few exceptions are the penicillins, griseofulvin, fumagillin and variotin, produced by fungi, and a group of antibiotics produced by bacteria: bacitracin, tyrothricin, polymyxin B, and colistin. There are over 400 antibiotic compounds and preparations derived from actinomycetes (3). Their combined spectrum of inhibitory action includes protozoa, (4), algae (5), tumor cells, fungi, spirochetes, bacteria, rickettsiae, pleuropneumonia-like organisms, and...References1. GOLDSTOUTPAGANODONOVICK WHAJFR: Amphotericins A & B, antifungal antibiotics produced by a streptomycete, I. In vitro studies, in Antibiotics Annual 1955-1956, Medical Encyclopedia, Inc., New York, 1956, p. 579. Google Scholar2. WAKSMAN S: Outstanding problems in the study of antibacterial and antifungal antibiotics, with special reference to the antibiotics of actinomycetes, in Therapy of Fungus Diseases, edited by STERNBERG, T. H., Little Brown and Company, Boston, 1955, p. 3. Google Scholar3. WAKSMANLECHEVALIER SAHA: The actinomycetes, in Vol. III. Antibiotics of Actinomycetes. The Williams & Wilkins Company, Baltimore, 1962, p. 11. Google Scholar4. FURTADO TA: Clinical results in the treatment of American leishmaniasis with oral and intravenous amphotericin, in Antibiotics Annual 1959-1960, Antibiotica, Inc., New York, 1960, p. 631. Google Scholar5. LAMPENARNOW JOP: Inhibition of algae by nystatin. J. Bact. 82: 247, 1961. CrossrefMedlineGoogle Scholar6. VINING LC: The polyene antifungal antibiotics. Hindustan Antibiot. Bull. 3: 37, 1960. MedlineGoogle Scholar7. OLANSKYOLANSKY SM: Topical treatment of cutaneous moniliasis with an amphotericin lotion. Antibiot. Chemother. 12: 650, 1962. Google Scholar8. ROSENTHAL AL: The effect of amphotericin lotion on cutaneous moniliasis. Arch. Derm. (Chicago) 87: 270, 1963. CrossrefMedlineGoogle Scholar9. LOURIA DB: Some aspects of the absorption, distribution, and excretion of amphotericin B in man. Antibiot. Med. 5: 295, 1958. Google Scholar10. DUNNMCMILLENCORNBLEET YOST: Oral amphotericin B therapy in blastomycosis. Arch. Derm. (Chicago) 88: 75, 1963. CrossrefMedlineGoogle Scholar11. LITTMANHOROWITZSWADEY MLPLJG: Coccidioidomycosis and its treatment with amphotericin B. Amer. J. Med. 24: 568, 1958. CrossrefMedlineGoogle Scholar12. BAUMSCHWARZ GLJ: Clinical experiences with amphotericin B, in Antibiotics Annual 1959-1960, Antibiotica, Inc., New York, 1960, p. 638. Google Scholar13. MARTINNICHOLSSVIENULRICH WJDRHJJA: Cryptococcosis. Arch. Intern. Med. (Chicago) 104: 4, 1959. CrossrefGoogle Scholar14. STOUGHGROELKROEGER ARJTWH: Amphotericin B, a new antifungal agent for the prophylaxis of antibiotic-induced moniliasis. Antibiot. Med. 6: 653, 1959. Google Scholar15. LYNCHFURCOLOWYATESTOSHLARSH HJMLJLFEHW: Toxicity and absorption studies in humans of newer antifungal agents, in Antimicrobial Agents Annual 1960, Plenum Press, New York, 1961, p. 551. Google Scholar16. UTZLOURIAFEDEREMMONSMCCULLOUGH JPDBNCWNE: A report of clinical studies on the use of amphotericin in patients with systemic fungal diseases, in Antibiotics Annual 1957-1958, Medical Encyclopedia, Inc., New York, 1958, p. 65. Google Scholar17. HALDENEWCOMERWRIGHTSTERNBERG CVDETTH: An evaluation of amphotericin B in vitro and in vivo in mice against Coccidioides immitis and Candida albicans, and preliminary observations concerning the administration of amphotericin B to man. J. Invest. Derm. 28: 217, 1957. CrossrefMedlineGoogle Scholar18. APPELBAUMSHTOKALKO ES: Cryptococcus meningitis arrested with amphotericin B. Ann. Intern. Med. 47: 346, 1957. LinkGoogle Scholar19. NEWCOMERSTERNBERGWRIGHTREISNER VDTHETRM: Current status of amphotericin B in the treatment of the systemic fungus infections. J. Chronic Dis. 9: 354, 1959. CrossrefGoogle Scholar20. BIDDLEKOENIG AH: An agent effective against cryptococcosis of the central nervous system. Arch. Intern. (Chicago) 102: 801, 1958. CrossrefGoogle Scholar21. LEHANFURCOLOWBRASHERLARSH PHMLCAHW: Therapeutic trials with the newer antifungal agents, in Antibiotics Annual 1956-1957, Medical Encyclopedia, Inc., New York, 1957, p. 467. Google Scholar22. KLAPPERSMITHCONANT MSDTNF: Disseminated coccidioidomycosis apparently cured with amphotericin B. JAMA 167: 463, 1958. CrossrefMedlineGoogle Scholar23. FIESE MJ: Treatment of disseminated coccidioidomycosis with amphotericin B. Calif. Med. 86: 119, 1957. MedlineGoogle Scholar24. BENNETT JE: Unpublished observations. Google Scholar25. HALDEWRIGHTPOLLARDNEWCOMERSTERNBERG CETWHVDTH: The effect of amphotericin B upon the yeast flora of the gastrointestinal tract of man, in Antibiotics Annual 1956-1957, Medical Encyclopedia, Inc., New York, 1957, p. 123. Google Scholar26. LEPPERSPIESRUBENIS MHHWM: Use of amphotericin to eliminate Candida from the stools of infants treated with tetracycline, in Antibiotics Annual 1958-1959, Medical Encyclopedia, Inc., New York, 1959, p. 672. Google Scholar27. SEABURYDASCOMB JHHE: Experience with amphotericin B for the treatment of systemic mycoses. Arch. Intern. Med. (Chicago) 102: 960, 1958. CrossrefGoogle Scholar28. LEHANYATESBRASHERLARSHFURCOLOW PHJLCAHWML: Experiences with the therapy of sixty cases of deep mycotic infections. Dis. Chest 32: 597, 1957. CrossrefMedlineGoogle Scholar29. HARRELLCURTIS ERAC: The treatment of North American blastomycosis with amphotericin B. Arch. Derm. (Chicago) 76: 561, 1957. CrossrefGoogle Scholar30. BARTNERZINNESMOEKULESZA EHRAJS: Studies on a new solubilized preparation of amphotericin B, in Antibiotics Annual 1957-1958, Medical Encyclopedia, Inc., New York, 1958, p. 53. Google Scholar31. BENNETTHILLBUTLEREMMONS JEGJWTCW: Correlation of particle size of intravenous amphotericin B with toxic and chemotherapeutic effects, in Antimicrobial Agents and Chemotherapy 1963, American Society for Microbiology, Ann Arbor, 1964. p. 745. Google Scholar32. BUTLERHILLSZWEDKNIGHT WTGJCFV: Amphotericin B renal toxicity in the dog. J. Pharmacol. Exp. Ther. 143: 47, 1964. MedlineGoogle Scholar33. VOGELCRUTCHER RAJC: Studies on the bioassay and excretion of amphotericin B in patients with systemic mycoses. Antibiot. Med. 5: 501, 1958. Google Scholar34. TAYLORLYNCHTAYLORWEISER RLHPRROL: The determination of amphotericin B serum levels in man, in Transactions of the 17th Conference on the Chemotherapy of Tuberculosis, edited by U. S. Veterans Administration, Department of Medicine and Surgery, Washington, D. C., 1958, p. 328. Google Scholar35. KRAVETZANDRIOLEHUBERUTZ HMVTMAJP: Oral administration of solubilized amphotericin B. New Eng. J. Med. 265: 183, 1961. CrossrefMedlineGoogle Scholar36. COSTELLODEFEOLITTMAN MJCPML: Chromoblastomycosis treated with local infiltrate of amphotericin B solution. Arch. Derm. (Chicago) 79: 184, 1959. CrossrefGoogle Scholar37. SPICKARDBUTLERANDRIOLEUTZ AWTVTJP: The improved prognosis of cryptococcal meningitis with amphotericin B therapy. Ann. Intern. Med. 58: 66, 1963. LinkGoogle Scholar38. SEABURYDASCOMB JHHE: Experience with amphotericin B. Ann. NY Acad. Sci. 89: 202, 1960. CrossrefMedlineGoogle Scholar39. FOSTERALMEDALITTMANWILSON JBEMLME: Some intraocular and conjunctival effects of amphotericin B in man and in the rabbit. Arch. Ophthal. (Chicago) 60: 555, 1958. CrossrefMedlineGoogle Scholar40. FINDLAYKLEINFELD CWG: Monilial empyema treated successfully with intrapleural instillations of amphotericin B. J. Thorac. Cardiov. Surg. 38: 244, 1959. CrossrefMedlineGoogle Scholar41. SAROTLITTMANCERRUTI IAMLMM: Intrathoracic injection of amphotericin B in the treatment of monilial empyema. Sea View Hosp. Bull. 17: 95, 1959. MedlineGoogle Scholar42. MCNALLHALDENEWCOMERSTERNBERG EGCVDTH: A biological assay for the determination of amphotericin A & B in biological fluids, in Antibiotics Annual 1957-1958, Medical Encyclopedia, Inc., New York, 1958, p. 131. Google Scholar43. PERLMANGIUFFREBRINDLE DNASA: Use of Fungizone® in control of fungi and yeasts in tissue culture. Proc. Soc. Exp. Biol. Med. 106: 880, 1961. CrossrefMedlineGoogle Scholar44. ACTORWINDPAGANO PSJF: Potentiation of amphotericin B activity against Trypanosoma congolense in mice. Proc. Soc. Exp. Biol. Med. 110: 409, 1962. CrossrefMedlineGoogle Scholar45. HOWARD DM: Effect of mycostatin and fungizone on the growth of Histoplasma capsulatum in tissue culture. J. Bact. 79: 442, 1960. CrossrefMedlineGoogle Scholar46. RIESELBACHMORSERALLFREIFREIREICH REEEDPEEJ: Intrathecal aminopterin therapy of meningeal leukemia. Arch. Intern. Med. (Chicago) 111: 620, 1963. CrossrefMedlineGoogle Scholar47. RIESELBACHDI CHIROFREIREICHRALL REGEJDP: Subarachnoid distribution of drugs after lumbar injection. New Eng. J. Med. 267, 1273, 1962. CrossrefMedlineGoogle Scholar48. OMMAYA AK: Subcutaneous reservoir and pump for sterile access to ventricular cerebrospinal fluid. Lancet 2: 983, 1963. CrossrefMedlineGoogle Scholar49. LAMPENARNOWSAFFERMAN JOPMRS: Mechanism of protection by sterols against polyene antibiotics. J. Bact. 80: 200, 1960. CrossrefMedlineGoogle Scholar50. HARSCHLAMPEN MJO: Modification of K+ transport in yeast by the polyene antifungal antibiotic N-acetylcandidin. Biochem. Pharmacol. 12: 875, 1963. CrossrefMedlineGoogle Scholar51. HEMPHILLHERMANYOUNG JJYFVM: Comparative antifungal activity of nystatin and amphotericin B in tissue culture for virus propagation, in Antibiotics Annual 1957-1958, Medical Encyclopedia, Inc., New York, 1958, p. 961. Google Scholar52. KINSKYAVRUCHPERMUTTROGERS SCJMHB: The lytic effect of polyene antifungal antibiotics on mammalian erythrocytes. Biochem. Biophys. Res. Commun. 9: 503, 1962. CrossrefMedlineGoogle Scholar53. OAKAWANATSUSHITA KM: Hemolytic study of amphotericin B. J. Ther. (Tokyo) 44: 2305, 1962. Google Scholar54. RAGNISZYBALSKIBOROWSKISCHAFFNER GWECP: N-acetyl-candidin, a water-soluble polyene antibiotic for fungal prophylaxis and decontamination of tissue cultures. Antibiot. Chemother. 11: 797, 1961. Google Scholar55. LECHEVALIERBOROWSKILAMPENSCHAFFNER HEJOCP: Water-soluble N-acetyl derivatives of heptaene macrolide antifungal antibiotics: microbiological studies. Antibiot. Chemother 11: 640, 1961. Google Scholar56. GROEL JT: Amphotericin B reactions. Amer. Rev. Resp. Dis. 88: 565, 1963. Google Scholar57. TYNESUTZBENNETTALLING BSJPJEDW: Reducing amphotericin B reactions. Amer. Rev. Resp. Dis. 87: 264, 1963. MedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: JOHN E. BENNETT, M.D.Affiliations: Bethesda, Maryland*Mycostatin® and Fungizone® are the trade names given to nystatin and amphotericin B by E. R. Squibb & Sons, New York.†Candeptin, produced by Julius Schmid, Inc., New York. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byToxicokinetics and Toxicodynamics of Anti-infective AgentsAmphotericin B: How Much Is Enough?Novel Administrations of AntifungalsNovel modes of antifungal drug administrationDelirium and depression associated with amphotericin BSTRUCTURE SIDE-EFFECT SORTING OF DRUGS.The Nephrotoxicity of Antimicrobial AgentsChemistry and biology of the polyene macrolide antibioticsChemistry and biology of the polyene macrolide antibioticsREPORT OF THE AD‐HOC COMMITTEE ON RATIONALIZATION OF FACILITIES FOR ORGAN TRANSPLANTATION AND RENAL DIALYSISSurface chemical and micellar properties of drugs in solutionAmphotericin b Therapy in the Treatment of Presumed Histoplasma Chorioretinitis 1 August 1964Volume 61, Issue 2Page: 335-340KeywordsAmphotericinAntibioticsBacteriaCellsNystatinPenicillinPharmacologyPolymyxinsSpirochetes ePublished: 1 December 2008 Issue Published: 1 August 1964 PDF downloadLoading ...